Industry Reports
![](https://drugchannelsinstitute.com/wp-content/uploads/2012/11/2024-PharmacyPBM-DCI-cover-193w.png )
The 2024 Economic Report on U.S. Pharmacies and Pharmacy Benefit Managers
The ultimate guide to the complex web of interactions within the U.S. prescription distribution and reimbursement system more >
![](https://drugchannelsinstitute.com/wp-content/uploads/2012/11/2023-24-PharmaWholesalers-cover-193w.png )
The 2023-24 Economic Report on Pharmaceutical Wholesalers and Specialty Distributors
The most comprehensive tool for analyzing the economic and business realities of the U.S. pharmaceutical distribution industry. more >
From The Drug Channels Blog
Friday, July 12, 2024
At the Breaking Point: The Unsustainable Future of Government Drug Discount Programs
Today’s guest post comes from Gavin Magaha, Senior Director of External Affairs and Policy at Kalderos. Gavin discusses the three key reasons for duplicate discounts between the 340B more >
Tuesday, July 9, 2024
Who Will Pay for Prescription Drugs in 2032: Four Takeaways from the New Government Forecasts
The econowonks at the Centers for Medicare & Medicaid Services (CMS) recently released the latest projections for U.S. spending on healthcare. (See links below.) These data provide the latest official more >